SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen Preferred and Income Fund (JPT) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 62/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JPT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.67
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$1.68 |
$11.56M |
$11.43M |
98.9% |
| 2018 |
$-0.22 |
$-1.26M |
$-1.43M |
- |
| 2019 |
$1.77 |
$12.21M |
$12.07M |
98.9% |
| 2020 |
$0.02 |
$298.46K |
$146.85K |
49.2% |
| 2021 |
$3.62 |
$24.93M |
$24.79M |
99.4% |
| 2022 |
$-4.67 |
$-13.15M |
$-25.7M |
- |
